Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeU.S. Transparency Report

      U.S. Transparency Report

      5 things to know about the 2018 Janssen U.S. Transparency Report

      The company just released its third annual report and leaders from across Janssen share some top takeaways, including a new initiative to include the list price and potential out-of-pocket costs for its most frequently prescribed medicine.

      20 inspiring stories of progress and hope for the future of healthcare

      From breakthrough work to eradicate some of the world’s deadliest diseases to advancements in cutting-edge health technology, see just some of the ways Johnson & Johnson is working to help change the trajectory of health for humanity.

      Johnson & Johnson Chairman and CEO Alex Gorsky appears on Bloomberg Big Decisions

      See what Alex Gorsky had to say about his goal to help change the trajectory of health for humanity—and how he believes the U.S. healthcare system must change for the better.

      5 things to know about the 2017 Janssen U.S. Transparency Report

      The company just released its second-annual report and we’re spotlighting the top takeaways for patients, consumers and healthcare professionals, including a look at how Janssen approaches drug pricing.

      Johnson & Johnson leaders make Fortune‘s 2017 Most Powerful Women list

      Group Worldwide Chair Sandi Peterson and Company Group Chairman, Pharmaceuticals, The Americas Jennifer Taubert are honorees once again this year.

      Janssen Pharmaceuticals releases a 2016 U.S. Transparency Report

      Jennifer Taubert, Company Group Chairman, Pharmaceuticals, The Americas, explains why Janssen is sharing information around its medication pricing and other business practices.